CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

Traynor Capital Management, Inc.'s Holding History (CIK: 0001666786)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021

Shares 26,195 Value ($000) $2,932 Avg Close $125.59 Range $109.63 - $163.00

Q2 2021

Shares 14,947 Value ($000) $2,329 Avg Close $121.62 Range $95.11 - $169.76

Q1 2021

Shares 2,386 Value ($000) $290 Avg Close $151.00 Range $100.00 - $220.20

Q4 2020

Shares 2,355 Value ($000) $360 Avg Close $118.20 Range $79.31 - $181.42

Q3 2020

Shares 2,295 Value ($000) $212 Avg Close $88.70 Range $74.00 - $105.12

Q3 2019

Shares 6,845 Value ($000) $280 Avg Close $47.78 Range $40.70 - $53.90

Q2 2019

Shares 6,470 Value ($000) $308 Avg Close $39.97 Range $34.91 - $48.30

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2021	26,195	$2,932	$125.59	$109.63 - $163.00
Q2 2021	14,947	$2,329	$121.62	$95.11 - $169.76
Q1 2021	2,386	$290	$151.00	$100.00 - $220.20
Q4 2020	2,355	$360	$118.20	$79.31 - $181.42
Q3 2020	2,295	$212	$88.70	$74.00 - $105.12
Q3 2019	6,845	$280	$47.78	$40.70 - $53.90
Q2 2019	6,470	$308	$39.97	$34.91 - $48.30